Drugs / α-lipoic acid

Trials 2 · a red edge is where a trial was stopped

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT02966665 Sep 2008 → Aug 2026 overdue chronic obstructive pulmonary disease, heart failure, pulmonary arterial hypertension Russell Richardson Recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT00116207 Jan 2000 → Sep 2009 diabetic autonomic neuropathy University of Michigan Completed No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT02056366 Comparator Jan 2010 → Sep 2013 diabetic autonomic neuropathy, type 2 diabetes mellitus The Catholic University of Korea Completed No outcome recorded
Phase not applicable2 trials
NCT03601494 Comparator Feb → Nov 2017 chronic pain syndrome, diabetic neuropathy Assiut University Completed No outcome recorded
NCT02971878 Comparator Nov 2016 → Feb 2018 Fertilitetscentrum AB Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as α-lipoic acid “antioxidant treatment with allopurinol, α-lipoic acid and nicotinamide, or placebo.” PMID 23740194 Jun 2013
4

“vitamin B complex, α lipoic acid, selective serotonin reuptake inhibitor (SSRI)” NCT03601494

NCT02971878

NCT02966665

NCT02056366

Known as ALA “Human embryos will be cultured in media that contains 3 antioxidants (Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA)) that can be found in the in...” NCT02971878
Route Oral “α-lipoic acid 600mg PO medication,Per day, For 6weeks α-lipoic acid 1200mg PO medication,Per day, For 6weeks” NCT02056366